HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Seeks International Input On Sunscreen Monograph

This article was originally published in The Rose Sheet

Executive Summary

With a final sunscreen rule targeted for the fall, FDA plans to discuss proposed requirements with regulators from the European Union, Canada and Japan at the International Cooperation on Cosmetics Regulation meeting in Toronto July 13-15

You may also be interested in...



Council, Campaign Vie For Influence In Washington: Top Stories Of 2010

Developments in the natural/organic marketplace, FDA's pending sunscreen monograph, the regulatory fate of controversial cosmetic ingredients and the larger question of how the personal-care industry should be policed drove interest among manufacturers and stakeholders in 2010.

Council, Campaign Vie For Influence In Washington: Top Stories Of 2010

Developments in the natural/organic marketplace, FDA's pending sunscreen monograph, the regulatory fate of controversial cosmetic ingredients and the larger question of how the personal-care industry should be policed drove interest among manufacturers and stakeholders in 2010.

International Regulators Endorse Definition For Nanotech In Cosmetics

At its fourth annual meeting July 13-15 in Toronto, members of the International Cooperation for Cosmetics Regulation endorsed a working definition for nanotechnology in cosmetics

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel